Latest bladder cancer Stories
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
Researchers released some pretty incredible findings last week about cancer. In a multiple institute study, researchers looked closely at how cancers are classified.
Takeda Pharmaceuticals Co. and Eli Lilly & Co.
The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform
BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB)
Micromedic to continue developing its CellDetect® technology for monitoring the recurrence of bladder cancer TEL AVIV, Israel, July 1, 2014 /PRNewswire/ -- BioLight
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation.
In light of Blue Cross and Blue Shield of Massachusetts’ recent Actos lawsuit, Flood Law Group announces it is investigating potential Actos claims. Washington,
SAN DIEGO, June 17, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc.
- A transitional zone between two communities containing the characteristic species of each.